Which first-generation antipsychotics should be “repurposed” for the treatment of schizophrenia
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1433-8491
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Which first-generation antipsychotics should be “repurposed” for the treatment of schizophrenia ; volume:272 ; number:1 ; day:17 ; month:1 ; year:2022 ; pages:1-3 ; date:2.2022
European archives of psychiatry and clinical neuroscience ; 272, Heft 1 (17.1.2022), 1-3, 2.2022
- Creator
-
Leucht, Stefan
Davis, John M.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00406-021-01378-1
- URN
-
urn:nbn:de:101:1-2022050821160362831370
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Leucht, Stefan
- Davis, John M.
- SpringerLink (Online service)
Other Objects (12)
Should ‘typical’, first-generation antipsychotics no longer be generally used in the treatment of schizophrenia?
Impact of adverse reactions to first-generation antipsychotics on treatment adherence in outpatients with schizophrenia: a cross-sectional study
Cost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses
Cost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses
Can Antipsychotics Improve Social Cognition in Patients with Schizophrenia?
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Stroke Risk Among Non-Elderly Users of Haloperidol or First-Generation Antipsychotics vs Second-Generation Antipsychotics: A Cohort Study from a US Health Insurance Claims Database
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
Serum prolactin levels and sexual dysfunction in patients with schizophrenia treated with antipsychotics: comparison between aripiprazole and other atypical antipsychotics
Clinical and economic ramifications of switching antipsychotics in the treatment of schizophrenia
A study of antioxidant activity in patients with schizophrenia taking atypical antipsychotics
Current antipsychotics
Should ‘typical’, first-generation antipsychotics no longer be generally used in the treatment of schizophrenia?
Impact of adverse reactions to first-generation antipsychotics on treatment adherence in outpatients with schizophrenia: a cross-sectional study
Cost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses
Cost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses
Can Antipsychotics Improve Social Cognition in Patients with Schizophrenia?
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Stroke Risk Among Non-Elderly Users of Haloperidol or First-Generation Antipsychotics vs Second-Generation Antipsychotics: A Cohort Study from a US Health Insurance Claims Database
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
Serum prolactin levels and sexual dysfunction in patients with schizophrenia treated with antipsychotics: comparison between aripiprazole and other atypical antipsychotics
Clinical and economic ramifications of switching antipsychotics in the treatment of schizophrenia
A study of antioxidant activity in patients with schizophrenia taking atypical antipsychotics
Current antipsychotics
Should ‘typical’, first-generation antipsychotics no longer be generally used in the treatment of schizophrenia?
Impact of adverse reactions to first-generation antipsychotics on treatment adherence in outpatients with schizophrenia: a cross-sectional study
Cost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses
Cost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses
Can Antipsychotics Improve Social Cognition in Patients with Schizophrenia?
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Stroke Risk Among Non-Elderly Users of Haloperidol or First-Generation Antipsychotics vs Second-Generation Antipsychotics: A Cohort Study from a US Health Insurance Claims Database
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
Serum prolactin levels and sexual dysfunction in patients with schizophrenia treated with antipsychotics: comparison between aripiprazole and other atypical antipsychotics
Clinical and economic ramifications of switching antipsychotics in the treatment of schizophrenia
A study of antioxidant activity in patients with schizophrenia taking atypical antipsychotics